“With the number of new drugs and biologics going up day by day, there has never been a better time to invest in biotech stocks,” declares the author of today’s article. With the biotech industry consistently outperforming the S&P 500, he proceeds to highlight three particular biotech companies that he believes are solid buys right now – and which have the potential to make investors rich. For more, CLICK HERE.